Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
CANbridge Pharmaceuticals Inc. ( (HK:1228) ) has shared an announcement.
CANbridge Pharmaceuticals Inc. has announced a trading halt on its shares on the Hong Kong Stock Exchange, effective from August 12, 2025. This halt is pending the release of an announcement containing inside information, which may have significant implications for the company’s operations and its stakeholders.
More about CANbridge Pharmaceuticals Inc.
CANbridge Pharmaceuticals Inc. is a biopharmaceutical company incorporated in the Cayman Islands, focusing on developing and commercializing innovative therapies for rare diseases and targeted cancers.
Average Trading Volume: 10,906,976
Technical Sentiment Signal: Buy
Current Market Cap: HK$573.5M
For a thorough assessment of 1228 stock, go to TipRanks’ Stock Analysis page.